Braidwell »

Avalo Therapeutics Ord shares owned by Braidwell

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Braidwell

Quarter filed Position value Share count Share price at filing
2026-06-30 $30M 1.6M 18.48

More positions owned by Braidwell

Caris Life Sciences (CAI)
Hinge Health Cl A (HNGE)
Glaukos (GKOS)
Edgewise Therapeutics (EWTX)
Spyre Therapeutics Com New (SYRE)
Irhythm Technologies (IRTC)
Neogenomics Com New (NEO)
Kodiak Sciences (KOD)
Xenon Pharmaceuticals (XENE)
Alphatec Hldgs Note 0.750% 3/1 (Principal)
Monte Rosa Therapeutics (GLUE)
Dianthus Therapeutics (DNTH)
Neurocrine Biosciences (NBIX)
Alphatec Hldgs Com New (ATEC)
Generate Biomedicines Com Shs (GENB)

View all positions for Braidwell

Top funds holding Avalo Therapeutics Ord

FMR
Affinity Asset Advisors
Point72 Asset Management
Vanguard Capital Management
BVF
Nantahala Capital Management
Adage Capital Partners GP
Soleus Capital Management
Caligan Partners
Braidwell
venBio Select Advisor
Logos Global Management
Alliancebernstein
UBS Group
Geode Capital Management

View all funds holding Avalo Therapeutics Ord